Cardinal Health (NYSE:CAH) Price Target Raised to $232.00

Cardinal Health (NYSE:CAH) had its price target upped by Argus from $211.00 to $232.00 in a report issued on Friday,MarketScreener reports. Argus currently has a buy rating on the stock.

Other analysts have also issued reports about the company. Wells Fargo & Company lifted their price target on Cardinal Health from $221.00 to $237.00 and gave the company an “overweight” rating in a research note on Thursday, January 15th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday. TD Cowen lifted their target price on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Robert W. Baird set a $250.00 target price on shares of Cardinal Health in a report on Wednesday, January 14th. Finally, Mizuho set a $222.00 price target on shares of Cardinal Health in a research report on Monday, January 12th. Fourteen analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $221.07.

Cardinal Health Price Performance

CAH stock opened at $208.29 on Friday. The stock has a market cap of $49.49 billion, a price-to-earnings ratio of 31.42, a P/E/G ratio of 1.41 and a beta of 0.65. The company has a 50 day simple moving average of $205.78 and a 200 day simple moving average of $176.35. Cardinal Health has a 1 year low of $120.72 and a 1 year high of $215.48.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company’s revenue was up 22.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts anticipate that Cardinal Health will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were paid a $0.5107 dividend. The ex-dividend date was Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s payout ratio is currently 30.77%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of CAH. Redhawk Wealth Advisors Inc. raised its holdings in shares of Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after purchasing an additional 48 shares during the period. HF Advisory Group LLC increased its position in Cardinal Health by 0.9% in the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after buying an additional 49 shares in the last quarter. Latitude Advisors LLC raised its stake in Cardinal Health by 2.1% during the 3rd quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock worth $408,000 after buying an additional 53 shares during the period. Barnes Dennig Private Wealth Management LLC raised its stake in Cardinal Health by 38.7% during the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock worth $39,000 after buying an additional 53 shares during the period. Finally, MFA Wealth Services boosted its holdings in Cardinal Health by 2.3% in the third quarter. MFA Wealth Services now owns 2,491 shares of the company’s stock worth $391,000 after acquiring an additional 55 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.